Orthopedic: BioMimetic Therapeutics, Inc. (BMTI)

• Publication date: April 2012
• Report size: 58 pages

This report is a source for data, analysis and actionable intelligence on the BioMimetic Therapeutics, Inc. portfolio of new product development . The report provides detailed analysis on each pipeline product with data on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date. Each pipeline product is profiled to cover data on product descript...

This report is a source for data, analysis and actionable intelligence on the BioMimetic Therapeutics, Inc. portfolio of new product development . The report provides detailed analysis on each pipeline product with data on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.

Each pipeline product is profiled to cover data on product description, function, technology, indication, and application. The report is also supplemented with a detailed industry player profile and data on clinical trials, wherever applicable.

Scope of the Research

- Detailed industry player profile with data on business description, key industry player facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
- Detailed coverage on all the new product development, by equipment type, by therapy area, by development stage, and by trial phase.
- Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
- Profile of each pipeline product with additional data on product description, function, technology, indication(s), and application.
- Data on relevant clinical trials and product patent details, wherever applicable.
- Information on clinical trial, wherever applicable, is supplemented with data on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Buy

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
- Design and develop your product development, industry ing and sales strategies.
- Exploit Merger and Acquisition opportunities by identifying industry players with the most innovative pipeline.
- Develop successful market-entry strategies .
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Develop competition strategies by identifying the status and likely launch of your competitors’ new product development through review of the clinical trials, stage and phase of development, etc.
- Which are the next high-value products that your competitor would add in its portfolio? – identify, understand and capitalize.

Blood Supply, Tissue Banking And Transplantation Industry

Data table of Contents
Data table of Contents 2
List of Tables 4
List of Figures 5
BioMimetic Therapeutics, Inc. - Business Overview 6
Key Facts 6
BioMimetic Therapeutics, Inc. - Major Products and Services 7
BioMimetic Therapeutics, Inc. Pipeline Products by Equipment Type 8
BioMimetic Therapeutics, Inc. Pipeline Products by Development Stage 9
BioMimetic Therapeutics, Inc. Pipeline Products by Therapy Area 10
BioMimetic Therapeutics, Inc. Pipeline Products by Trial Phase 11
BioMimetic Therapeutics, Inc. Pipeline Products by Milestone Summary 12
August ment Acute Tendon 13
Product Status 13
Product Description 13
Product Patent Details 13
August ment Bone Graft 14
Product Status 14
Product Description 14
Product Milestone 15
August ment Bone Graft Clinical Trial 15
Product Patent Details 17
August ment C 18
Product Status 18
Product Description 18
Product Patent Details 18
August ment CT 20
Product Status 20
Product Description 20
Product Patent Details 20
August ment Injectable Bone Graft 21
Product Status 21
Product Description 21
Product Milestone 22
August ment Injectable Bone Graft Clinical Trial 22
Product Pricing 24
Product Patent Details 24
August ment LT 25
Product Status 25
Product Description 25
Product Patent Details 26
August ment RC 27
Product Status 27
Product Description 27
Product Milestone 27
August ment RC Clinical Trial 28
Product Patent Details 29
August ment-Spine 30
Product Status 30
Product Description 30
Product Patent Details 30
BioMimetic Therapeutics, Inc. - Top Competitors 32
BioMimetic Therapeutics, Inc. - Key Executives 33
BioMimetic Therapeutics, Inc. - Key Employee Biographies 34
BioMimetic Therapeutics, Inc. - Operations and Subsidiaries 35
Head Office 35
Other Locations & Subsidiaries 35
Recent Developments 36
March 10, 2011: BioMimetic Reports Total Sales s Of US$ 1.5m In 2010 36
February 17, 2011: BioMimetic Therapeutics Highlights Commercial And Product Development Activities During AAOS 36
December 16, 2010: BioMimetic Therapeutics Secures Patent From CIPO 37
November 03, 2010: BioMimetic Reports Q3 2010 Results 37
October 01, 2010: Biomimetic To Invest US$ 20 Mln To Expand Tennessee Facility 38
September 30, 2010: BioMimetic Therapeutics Annouces Resignation Of Steven Hirsch As Executive Vice President, Orthopedics And COO 38
September 08, 2010: BioMimetic Completes Meeting With FDA For Review Of August ment Bone Graft 38
August 05, 2010: BioMimetic Reports Net Loss Of US$ 7.7 Mln For Q2 2010 39
May 27, 2010: BioMimetic To Hire 100 Sales Force To March ket Bone Graft 39
May 10, 2010: BioMimetic Therapeutics Reports Q1 2010 Results 39


List of Tables

BioMimetic Therapeutics, Inc., Major development 1
BioMimetic Therapeutics, Inc. Key Pipeline Products by Equipment Type 1
BioMimetic Therapeutics, Inc. Key Pipeline Products by Therapy Area 1
BioMimetic Therapeutics, Inc. Key Pipeline Products by Development Stage 1
BioMimetic Therapeutics, Inc. Key Pipeline Products by Trial Phase 1
BioMimetic Therapeutics, Inc., Major development 6
BioMimetic Therapeutics, Inc., Major Products and Services 7
BioMimetic Therapeutics, Inc. Number of Pipeline Products by Equipment Type 8
BioMimetic Therapeutics, Inc. Pipeline Products by Equipment Type 8
BioMimetic Therapeutics, Inc. Number of Pipeline Products by Development Stage 9
BioMimetic Therapeutics, Inc. Pipeline Products by Development Stage 9
BioMimetic Therapeutics, Inc. Number of Pipeline Products by Therapy Area 10
BioMimetic Therapeutics, Inc. Pipeline Products by Therapy Area 10
BioMimetic Therapeutics, Inc. Number of Pipeline Products by Trial Phase 11
BioMimetic Therapeutics, Inc. Pipeline Products by Trial Phase 11
BioMimetic Therapeutics, Inc. Number of Pipeline Products By Milestone Summary 12
BioMimetic Therapeutics, Inc. Pipeline Products by Milestone Summary 12
August ment Acute Tendon - Product Status 13
August ment Acute Tendon - Product Description 13
August ment Acute Tendon - Patent Details 13
August ment Bone Graft - Product Status 14
August ment Bone Graft - Product Description 14
August ment Bone Graft - Product Milestone 15
August ment Bone Graft - A Prospective, Randomized, Controlled, Multi-Center, Pivotal Human Clinical Trial To Evaluate The Safety And Effectiveness Of GEM OS1 Compared To Autologous Bone Graft As A Bone Regeneration Device In Foot And Ankle Fusions 15
August ment Bone Graft - Use of RhPDGF for foot and ankle fusions: A Prospective Study of 130 Fusions in 60 Patients 16
August ment Bone Graft - A Pilot Clinical Study Of GEM OS1 Bone Graft For The Treatment Of Distal Radius (Wrist) Fractures 16
August ment Bone Graft - Patent Details 17
August ment C - Product Status 18
August ment C - Product Description 18
August ment C - Patent Details 19
August ment CT - Product Status 20
August ment CT - Product Description 20
August ment CT - Patent Details 20
August ment Injectable Bone Graft - Product Status 21
August ment Injectable Bone Graft - Product Description 21
August ment Injectable Bone Graft - Product Milestone 22
August ment Injectable Bone Graft - GEM OS2 Injectable Bone Graft, For The Closed Treatment Of Distal Radius Fractures 22
August ment Injectable Bone Graft - Prospective, Randomized, Controlled, Multi-Center, Pivotal Clinical Trial to Evaluate the Safety and Effectiveness of August ment Injectable Bone Graft Compared to Autologous Bone Graft as a Bone Regeneration Device in Foot and Ankle Fusions 23
Product Pricing 24
August ment Injectable Bone Graft - Patent Details 24
August ment LT - Product Status 25
August ment LT - Product Description 25
August ment LT - Patent Details 26
August ment RC - Product Status 27
August ment RC - Product Description 27
August ment RC - Product Milestone 27
August ment RC - A Single Blinded, Multi-Center, Randomized, Controlled, Pilot Study To Evaluate The Safety And Performance Of August ment Rotator Cuff For Primary Surgical Treatment Of Full Thickness Rotator Cuff Tears 28
August ment RC - Patent Details 29
August ment-Spine - Product Status 30
August ment-Spine - Product Description 30
August ment-Spine - Patent Details 30
BioMimetic Therapeutics, Inc., Key Executives 33
BioMimetic Therapeutics, Inc., Key Employee Biographies 34
BioMimetic Therapeutics, Inc., Other Locations 35


List of Figures

BioMimetic Therapeutics, Inc. Key Pipeline Products by Equipment Type 1
BioMimetic Therapeutics, Inc. Pipeline Products by Equipment Type 8
BioMimetic Therapeutics, Inc. Pipeline Products by Development Stage 9
BioMimetic Therapeutics, Inc. Pipeline Products by Therapy Area 10
BioMimetic Therapeutics, Inc. Pipeline Products by Trial Phase 11
BioMimetic Therapeutics, Inc. Pipeline Products by Milestone Summary 12

Companies mentioned Stryker Corporation
DePuy Orthopaedics, Inc.
Zimmer Holdings, Inc.
Synthes GmbH
Musculoskeletal Transplant Foundation
Medtronic, Inc.
CryoLife, Inc.
Wright Medical Group, Inc.
Biomet, Inc.
Straumann Holding AG
Regeneration Technologies, Inc.
Exactech, Inc.